Data-driven computer simulation of human cancer cell

Annals of the New York Academy of Sciences

Volumn 1020, Issue , 2004, Pages 132-153

  Christopher, R ^a   Dhiman, A ^a   Fox, J ^a   Gendelman, R ^a   Haberitcher, T ^a   Kagle, D ^a   Spizz, G ^a   Khalil, I G ^a   Hill, C ^a  

^a Gene Network Sciences Inc   (United States)

Author keywords

Cancer; Cell; Computer; Data; Diagrammatic Cell Language (DCL); DigitalCell; Drug; Gene Network Sciences (GNS); Model; Simulation

Indexed keywords

DNA; PROTEIN; RNA;

APOPTOSIS; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; COMPUTER SIMULATION; CONFERENCE PAPER; DATA ANALYSIS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION SYSTEM; HUMAN; KINETICS; MOLECULAR MECHANICS; MOLECULAR MODEL; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SIMULATION; VALIDATION PROCESS;

EID: 2942576105     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1310.014     Document Type: Conference Paper

References (20)

1. LUNDBERG, A.S. & R.A. WEINBERG. 1999. Control of the cell cycle and apoptosis. Eur. J. Cancer 35(4): 531-539.
2. BALMAIN, A., J. GRAY & B. PONDER. 2003. The genetics and genomics of cancer. Nat. Genet. 33(suppl.): 238-244.
3. ANTONIOU, A.C., P.D. PHAROAH, G. MCMULLAN et al. 2001. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol. 21: 1-18.
4. ANTONIOU, A.C., P.D. PHAROAH, G. MCMULLAN et al. 2002. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2, and other genes. Br. J. Cancer 86: 76-83.
5. HEDENFALK, I., D. DUGGAN, Y. CHEN et al. 2001. Gene expression profiles in hereditary breast cancer. N. Engl. J. Med. 344: 539-548.
6. GRUVBERGER, S., M. RINGNER, Y. CHEN et al. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61: 5979-5984.
7. HEDENFALK, I., M. RINGNER, A. BEN-DOR et al. 2003. Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc. Natl. Acad. Sci. USA 100: 2532-2537.
8. PEROU, C.M., T. SORLIE, M.B. EISEN et al. 2000. Molecular portraits of human breast tumours. Nature 406: 747-752.
9. SORLIE, T., C.M. PEROU, R. TIBSHIRANI et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor sub-classes with clinical implications. Proc. Natl. Acad. Sci. USA 98: 10869-10874.
10. VAN'T VEER, L.J., H. DAI, M.J. VAN DE VIJVER et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
11. VAN DE VIJVER, M.J., Y.D. HE, L.J. VAN'T VEER et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999-2009.
12. WEST, M., C. BLANCHETTE, H. DRESSMAN et al. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA 98: 11462-11467.
13. PERI, S., J.D. NAVARRO, R. AMANCHY et al. 2003. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 13: 2363-2371.
14. MAIMON, R. & S. BROWNING. 2001. Diagrammatic notation and computational grammar for gene networks. International Conference on Systems Biology.
15. ARBER, N., Y. DOKI, E.K-H. HAN et al. 1997. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57: 1569-1574.
16. SAUTER, E.R., M. NESBIT, S. LITWIN et al. 1999. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. 59: 4876-4881.
17. SAUTER, E.R., M. HERLYN, S.C. LIU et al. 2000. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Clin. Cancer Res. 6: 654-660.
18. ZHOU, P., W. JIANG, Y-J. ZHANG et al. 1995. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11: 571-580.
19. JOHNSON, J., S. DECKER, D. ZAHAREVITZ et al. 2001. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br. J. Cancer 84(10): 1424-1431.
20. LEHMAN BROTHERS/MCKINSEY & CO. 2001. Report: The Fruits of Genomics. Lehman Brothers/McKinsey & Co.